These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28626620)

  • 1. Tissue Chips to aid drug development and modeling for rare diseases.
    Low LA; Tagle DA
    Expert Opin Orphan Drugs; 2016; 4(11):1113-1121. PubMed ID: 28626620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
    Low LA; Tagle DA
    Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.
    Donoghue L; Nguyen KT; Graham C; Sethu P
    Micromachines (Basel); 2021 Jan; 12(2):. PubMed ID: 33525451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue chips - innovative tools for drug development and disease modeling.
    Low LA; Tagle DA
    Lab Chip; 2017 Sep; 17(18):3026-3036. PubMed ID: 28795174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NIH microphysiological systems program: developing in vitro tools for safety and efficacy in drug development.
    Tagle DA
    Curr Opin Pharmacol; 2019 Oct; 48():146-154. PubMed ID: 31622895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance and potential roles of microphysiological systems in biology and medicine.
    Wikswo JP
    Exp Biol Med (Maywood); 2014 Sep; 239(9):1061-72. PubMed ID: 25187571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.
    Fabre KM; Delsing L; Hicks R; Colclough N; Crowther DC; Ewart L
    Adv Drug Deliv Rev; 2019 Feb; 140():129-135. PubMed ID: 30253201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organs-on-a-Chip.
    Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
    Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Chips in Space: Modeling Human Diseases in Microgravity.
    Low LA; Giulianotti MA
    Pharm Res; 2019 Dec; 37(1):8. PubMed ID: 31848830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human organ chips for regenerative pharmacology.
    Goyal G; Belgur C; Ingber DE
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01159. PubMed ID: 38149766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.
    Cavero I; Guillon JM; Holzgrefe HH
    Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphysiological Systems: Next Generation Systems for Assessing Toxicity and Therapeutic Effects of Nanomaterials.
    Ashammakhi N; Darabi MA; Çelebi-Saltik B; Tutar R; Hartel MC; Lee J; Hussein S; Goudie MJ; Cornelius MB; Dokmeci MR; Khademhosseini A
    Small Methods; 2020 Jan; 4(1):. PubMed ID: 33043130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vascular niche in next generation microphysiological systems.
    Ewald ML; Chen YH; Lee AP; Hughes CCW
    Lab Chip; 2021 Sep; 21(17):3244-3262. PubMed ID: 34396383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public-private partnerships.
    Livingston CA; Fabre KM; Tagle DA
    Comput Struct Biotechnol J; 2016; 14():207-210. PubMed ID: 27904714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development.
    Hargrove-Grimes P; Low LA; Tagle DA
    Cells Tissues Organs; 2022; 211(3):269-281. PubMed ID: 34380142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic Organs-on-a-Chip for Modeling Human Infectious Diseases.
    Wang Y; Wang P; Qin J
    Acc Chem Res; 2021 Sep; 54(18):3550-3562. PubMed ID: 34459199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organs-on-Chips Platforms Are Everywhere: A Zoom on Biomedical Investigation.
    Zommiti M; Connil N; Tahrioui A; Groboillot A; Barbey C; Konto-Ghiorghi Y; Lesouhaitier O; Chevalier S; Feuilloley MGJ
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microphysiological Blood-Brain Barrier Systems for Disease Modeling and Drug Development.
    Mulay AR; Hwang J; Kim DH
    Adv Healthc Mater; 2024 Mar; ():e2303180. PubMed ID: 38430211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.